Polyphenol-Rich Extract of Syzygium cumini Leaf Dually Improves Peripheral Insulin Sensitivity and Pancreatic Islet Function in Monosodium L-Glutamate-Induced Obese Rats by Jonas R. Sanches et al.
fphar-07-00048 March 8, 2016 Time: 17:57 # 1
ORIGINAL RESEARCH
published: 10 March 2016
doi: 10.3389/fphar.2016.00048
Edited by:
Adolfo Andrade-Cetto,
Universidad Nacional Autónoma
de México, Mexico
Reviewed by:
Marcia Hiriart,
Universidad Nacional Autónoma
de México, Mexico
Xiao Yu Tian,
The Chinese University of Hong Kong,
China
Alex Rafacho,
Federal University of Santa Catarina,
Brazil
*Correspondence:
Antonio Marcus de A. Paes
marcuspaes@ufma.br
Specialty section:
This article was submitted to
Ethnopharmacology,
a section of the journal
Frontiers in Pharmacology
Received: 10 October 2015
Accepted: 22 February 2016
Published: 10 March 2016
Citation:
Sanches JR, França LM, Chagas VT,
Gaspar RS, dos Santos KA,
Gonçalves LM, Sloboda DM,
Holloway AC, Dutra RP, Carneiro EM,
Cappelli AP and Paes AM (2016)
Polyphenol-Rich Extract of Syzygium
cumini Leaf Dually Improves
Peripheral Insulin Sensitivity
and Pancreatic Islet Function
in Monosodium L-Glutamate-Induced
Obese Rats. Front. Pharmacol. 7:48.
doi: 10.3389/fphar.2016.00048
Polyphenol-Rich Extract of Syzygium
cumini Leaf Dually Improves
Peripheral Insulin Sensitivity and
Pancreatic Islet Function in
Monosodium L-Glutamate-Induced
Obese Rats
Jonas R. Sanches1, Lucas M. França1, Vinicyus T. Chagas1, Renato S. Gaspar1,
Kayque A. dos Santos1, Luciana M. Gonçalves2, Deborah M. Sloboda3,
Alison C. Holloway4, Richard P. Dutra5, Everardo M. Carneiro2, Ana Paula G. Cappelli1
and Antonio Marcus de A. Paes1*
1 Laboratory of Experimental Physiology, Department of Physiological Sciences, Federal University of Maranhão, São Luís,
Brazil, 2 Laboratory of Endocrine Pancreas and Metabolism, Department of Estructural and Functional Biology, Institute of
Biology, State University of Campinas, Campinas, Brazil, 3 Departments of Biochemistry, Pediatrics and Obstetrics and
Gynecology, McMaster University, Hamilton, ON, Canada, 4 Department of Obstetrics and Gynecology, McMaster University,
Hamilton, ON, Canada, 5 Social, Health and Technological Sciences Center, Federal University of Maranhão, Imperatriz, Brazil
Syzygium cumini (L.) Skeels (Myrtaceae) has been traditionally used to treat a number
of illnesses. Ethnopharmacological studies have particularly addressed antidiabetic and
metabolic-related effects of extracts prepared from its different parts, especially seed,
and pulp-fruit, however. there is a lack of studies on phytochemical profile and biological
properties of its leaf. As there is considerable interest in bioactive compounds to
treat metabolic syndrome and its clustered risk factors, we sought to characterize
the metabolic effects of hydroethanolic extract of S. cumini leaf (HESc) on lean and
monosodium L-glutamate (MSG)-induced obese rats. HPLC-MS/MS characterization
of the HESc polyphenolic profile, at 254 nm, identified 15 compounds pertaining to
hydrolysable tannin and flavanol subclasses. At 60 days of age, both groups were
randomly assigned to receive HESc (500 mg/kg) or vehicle for 30 days. At the end
of treatment, obese+HESc exhibited significantly lower body weight gain, body mass
index, and white adipose tissue mass, compared to obese rats receiving vehicle.
Obese rats treated with HESc showed a twofold increase in lipolytic activity in the
periepididymal fat pad, as well as, brought triglyceride levels in serum, liver and skeletal
muscle back to levels close those found in lean animals. Furthermore, HESc also
improved hyperinsulinemia and insulin resistance in obese+HESc rats, which resulted in
partial reversal of glucose intolerance, as compared to obese rats. HESc had no effect
in lean rats. Assessment of ex vivo glucose-stimulated insulin secretion showed HESc
potentiated pancreatic function in islets isolated from both lean and obese rats treated
with HESc. In addition, HESc (10–1000 µg/mL) increased glucose stimulated insulin
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secretion from both isolated rat islets and INS-1E β-cells. These data demonstrate that
S. cumini leaf improved peripheral insulin sensitivity via stimulating/modulating β-cell
insulin release, which was associated with improvements in metabolic outcomes in
MSG-induced obese rats.
Keywords: metabolic syndrome, insulin resistance, hypertriglyceridemia, obesity, insulin secretion, jambolan,
polyphenols, complementary and alternative medicine
INTRODUCTION
The occurrence of the Metabolic Syndrome (MetS) has reached
epidemic proportions becoming a major socioeconomic issue
globally, affecting countries regardless of human development
index (HDI) values and ethnicity (O’Neill and O’Driscoll, 2015).
MetS is consensually defined as the co-occurrence of three out of
five possible dysfunctional characteristics: obesity/central obesity,
insulin resistance (IR), fasting hyperglycemia, hypertension, and
dyslipidemia, mainly observed as hypertriglyceridemia (Alberti
et al., 2009). Given this cluster of modifiable outcomes, as well
as their progressive pathophysiological changes, a variety of
complementary and alternative medicinal approaches, such
as practice of regular exercise, consumption of functional
foods and traditional herbal preparations, have been adopted
in addition to the pharmacological regimens commonly
used at distinct stages of MetS (Rubio-Ruiz et al., 2013). In
this scenario, herbal medicines have emerged as the leading
source of bioactive molecules to target MetS because of
their large-scale phytochemical diversity, which includes
numerous flavonoids, and polyphenolic-related compounds
(Arts and Hollman, 2005; Galleano et al., 2012; Song et al.,
2014).
Syzygium cumini (L.) Skeels (Fam.: Myrtaceae; Syn.: Syzygium
jambolanum (Lam.) DC, Eugenia jambolana Lam., Eugenia
cumini (L.) Druce) has been used for centuries by Indian
Ayurvedic medicine practitioners for diverse therapeutic
purposes (Ayyanar et al., 2013). However, it was only in the
mid to late nineteenth century that its particular capacity to
decrease urine sugar content in diabetic patients impelled
British traders to import it to Europe (Helmstadter, 2008).
Thereafter, S. cumini became a worldwide cultivated medicinal
plant, being popularly known as jamun in India, black plum in
Europe, jambolan in Spanish-spoken countries, and jambolão
in Brazil (Ayyanar and Subash-Babu, 2012). The antidiabetic
and other metabolic-related properties have been investigated
specially using the fruit and seeds, whereas the leaves have been
underused and under investigated (Ayyanar et al., 2013). The
antihyperglycemic impact of seed extracts has been demonstrated
in diabetic animal models (Ravi et al., 2004; Sharma et al., 2006,
2008). Administration of aqueous seed extract (400 mg/Kg/day,
21 days) to high-fat diet/streptozotocin-induced diabetic rats
reduced IR via upregulation of hepatic peroxisome proliferators-
activated receptors (PPAR-α and -γ) (Sharma et al., 2012).
Meanwhile, other metabolic-related properties such as anti-
hyperlipidemic and cardioprotective activities have been
attributed to insulin-independent mechanisms, e.g., inhibition
of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
reductase by ethanolic seed kernel extract (100 mg/Kg/day,
30 days) (Ravi et al., 2005) as well as reduction of atherosclerotic
apolipoprotein B100 synthesis by a fraction from aqueous fruit
pulp extract (20 mg/Kg/day, 30 days) (Tanwar et al., 2011)
in streptozotocin-induced diabetic rats. In a recent work, we
reviewed the main secondary metabolities that have been
reported in different parts of S. cumini, especially flavonoids
and polyphenolic-related compounds, correlating them to
the potential mechanisms of action that might underlie the
aforementioned pharmacological properties (Chagas et al.,
2015).
Most investigations of the metabolic properties of S. cumini
have been carried out in animals presenting with aggressive
hyperglycemia and elevated oxidative stress derived from
alloxan- or streptozotocin-induced diabetes, quite distinct
from the usual manifestations of human MetS. Animal
models of mild to moderate MetS, including the well-
validated monosodium L-glutamate (MSG)-induced obesity
model (Miranda et al., 2014) offer a more relevant opportunity
to further examine the pharmacological properties of S. cumini.
In this model, the administration of MSG to newborn rats result
in damage to the hypothalamic nuclei, particularly the median
eminence and arcuate nucleus, leading to impaired growth
hormone (GH) pulsatile secretion and autonomic nervous system
unbalance characterized by exacerbated parasympathetic tonus.
At adulthood, MSG-obese rats present with stunted growth,
abdominal obesity, hyperinsulinemia, IR, impaired glucose
tolerance, and dyslipidemia (Olney, 1969; Millard et al., 1982;
Miranda et al., 2014). We have recently shown that MSG-induced
dyslipidemia is mainly characterized by hypertriglyceridemia
subsequent to early activation of endoplasmic reticulum (ER)-
stress and IR in the liver (Franca et al., 2014).
In the present study, we took advantage of the prediabetic
MSG-obesity model to further investigate the metabolic
properties of the hydroethanolic extract of S. cumini leaf (HESc)
in rats. Here we show that phytochemical characterization
of HESc by HPLC-MS/MS mainly consists of hydrolysable
tannins and flavanols, which confer it an elevated antioxidant
capacity. After 30-days of oral treatment with HESc, obese
rats exhibited slower weight gain, abdominal fat mass loss,
serum and peripheral-tissue lipid profiles amelioration, and
attenuation of glucose intolerance, associated with the recovery
of peripheral insulin sensitivity and improvement of pancreatic
islet function. Lean HESc-treated rats did not show any
significant changes, although demonstrated increased insulin
release. This observation is consistent with a dual role for HESc,
and its polyphenolic compounds, as a stimulator/modulator of
insulin-glucose axis homeostasis in MSG-induced obese rats.
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RESULTS AND DISCUSSION
Antioxidant Capacity and HPLC-MS/MS
Characterization of HESc Polyphenolic
Profile
Flavonoids and polyphenolic-related compounds, abundant in
fruits, and vegetables are used for dietary and medicinal purposes,
and increasing evidence supports the beneficial effects of such
compounds on gluco-lipid homeostasis and the prevention of
metabolic diseases (Arts and Hollman, 2005). Thus, we first
assessed polyphenolic content and in vitro antioxidant capacity
of HESc. Prussian Blue method was applied to determine total
polyphenol content in HESc, which resulted in 23.0 ± 1.1
GAE/100 g. This polyphenolic content is higher than those
described in extracts prepared from other parts of the plant,
such as seed (Arun et al., 2011) and fruit (Veber et al.,
2015), but lower than those previously described to the leaf
(Ruan et al., 2008; Veber et al., 2015). However, in these
works, values would have been superstimated since authors
applied Folin–Ciacoteau method, which also quantifies non-
phenolic compounds like aromatic aminoacids, sugars, and
organic acids, making it inadvisable for total polyphenol
content quantifications (Prior et al., 2005). Assessment of
antioxidant capacity showed that HESc efficiently scavengers
both 2,2-diphenyl-1-picrylhydrazyl (DPPH•) and 2,2’-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS•+) radicals
(Figure 1). When compared to antioxidant standards, HESc
ability to scavenger DPPH was 4.5 times less than gallic acid (GA)
(HESc IC50 140.80± 1.20 µg/mL vs. GA IC50 30.5± 1.2 µg/mL,
insert in Figure 1A), whereas it showed higher potency against
ABTS•+, as compared to quercetin (HESc IC50 9.1 ± 1.2 µg/mL
vs. QCT 1.9 ± 1.2 µg/mL, insert in Figure 1B). Similar findings
have been shown for S. cumini leaf extracts, but at higher
inhibitory concentrations (Ruan et al., 2008; Jagetia et al., 2012).
Our data further support biological appliance of HESc, since
ABTS•+ method correlates with other antioxidant assays that
simulate physiological radical reactions, as well as, properly
depict the activity of polyphenols and flavonoids contained in
fruits, vegetables and their derivatives (Floegel et al., 2011).
HPLC-MS/MS was used to determine HESc polyphenolic
profile. Figure 2 shows the HPLC chromatogram, recorded at
254 nm. The information from the spectral data (Supplementary
Figure S1) was compared with published data to allow
the tentative identification of fifteen compounds (peaks
numbered 1–15 in Figure 2) pertaining to hydrolyzable tannins
(ellagitannins and gallotannins) and flavonols. Table 1 lists all
the compounds identified with their chromatographic retention
time and mass spectral data. Compound 1 was identified as
hexahydroxydiphenoyl-glucose (HHDP-glucose), whose [M–
H]− at m/z 481 fragmented to yield daughter ions at m/z 301
and 275. Compounds 2, 3, and 5 showed [M–H]− at m/z 783
and fragments at m/z 481, 301, and 275, which were identified
as isomers of di-HHDP-glucose, also known as pedunculagin
I (Gordon et al., 2011; Santos et al., 2011; Tala et al., 2013).
Compound 6 showed an [M–H]− at m/z 935, which yielded
a fragment at m/z 633 due to the loss of one unit of ellagic
FIGURE 1 | Antioxidant capacity of hydroethanolic extract of Syzygium
cumini leaf (HESc). Antioxidant capacity of HESc against the radicals (A)
1,1-diphenyl-2-picrylhydrazyl (DPPH•) and (B) 2,2′-azino-bis-3-
ethylbenzthiazoline-6-sulphonic acid (ABTS•+). Inserts represent inhibitory
concentration 50% (IC50) for HESc and standards gallic acid (GA) and
quercetin (QCT). Data represent mean or mean ± SEM from experiments run
in quadruplicate. ∗p < 0.05 analyzed by Student’s test.
acid (m/z 301). This compound was identified as di-HHDP-
galloyl-glucose, also known as casuarinin (Simirgiotis and
Schmeda-Hirschmann, 2010; Fischer et al., 2011). Compound 4,
which presented [M–H]− at m/z 761 with fragments at m/z 635
and 609, was identified as (epi) gallocatechin-(epi)gallocatechin-
O-gallate (Tala et al., 2013). Compounds 7, 8, 9, 10, and 12
were identified as galloyl monosaccharides, which resulted from
esterification of glucose by 3–5 GA units (galloyl, m/z 170).
Interestingly, it has been shown that the number of galloyl
units determine antioxidant capacity of galloylglucose isomers
(Ngoc et al., 2008). Peaks 11, 13, 14, and 15 were tentatively
identified as myricetin-derived compounds (Gordon et al., 2011).
Compound 11 was identified as myricetin deoxyhexoside due to
the loss of 146 Da from [M–H]− at m/z 463 to MS2 at m/z 317.
Compounds 13 and 14 were identified as isomers of acylated
myricetin deoxyhexoside since the decrease of [M–H]− from
m/z 505 to MS2 at m/z 463 may be ascribed to the loss of an
acyl group (m/z 42). Finally, compound 15, whose [M–H]−
at m/z 519 fragmented to yield MS2 at m/z 477, 331, and 315,
was identified as acylated methylmyricetin deoxyhexoside, once
the loss of 188 Da might correspond to an acylated hexose unit
(42+ 146 Da).
Previous work has shown S. cumini leaf to be rich in acylated
flavonol glycosides, especially myricetin, myricitrin, quercetin,
Frontiers in Pharmacology | www.frontiersin.org 3 March 2016 | Volume 7 | Article 48
fphar-07-00048 March 8, 2016 Time: 17:57 # 4
Sanches et al. Syzygium cumini Dual Effect in MSG-Obese Rats
FIGURE 2 | HPLC fingerprint of the hydroethanolic extract of S. cumini leaf (HESc). HPLC chromatogram with UV detection at 254 nm of hydroethanolic
extract of S. cumini leaf (HESc). Peak numbers correspond to tentatively identified compounds denoted in Table 1.
kaempferol, in addition to simple phenols, like ellagic acid, ferulic
acid, and GA (Ruan et al., 2008; Ayyanar and Subash-Babu,
2012). In our work, 4 out of 15 compounds identified in HESc
were myricetin-derived flavonols whose occurrence have been
already reported in S. cumini fruits (Gordon et al., 2011) and
leaves (Mahmoud et al., 2001). Myricetin and its derivatives have
been shown to improve insulin signaling pathways in skeletal
muscles (Tzeng et al., 2011) and adipocytes (Wang et al., 2015),
as well as, to protect pancreatic β-cells from cytokine-induced
cell death (Ding et al., 2012). It is noteworthy that ellagitannins
(compounds 1–3, 5, and 6) and gallotannins (compounds 7–10
and 12) were identified in our HESc, since these compounds have
been previously described only in jambolan pulp-fruit (Gordon
et al., 2011; Aqil et al., 2012). Antioxidant properties of these
ellagitannins are well documented (Fischer et al., 2011; Kahkonen
et al., 2012); for instance, casuarinin has been shown to inhibit
TABLE 1 | Tentative identification of polyphenolic profile of the hydroethanolic extract of Syzygium cumini leaves (HESc).
Peak tR (min) Compound [M–H]− (m/z) MS2 (m/z) Reference
1 4.1 HHDP-glucose 481 301, 275 Gordon et al., 2011
2 7.9 Di-HHDP-glucose 783 481, 301, 275 Gordon et al., 2011; Santos et al., 2011;
Tala et al., 2013
3 9.4 Di-HHDP-glucose 783 481, 301, 275 Gordon et al., 2011; Santos et al., 2011;
Tala et al., 2013
4 11.8 (epi)gallocatechin-(epi)gallocatechin-O-gallate 761 635, 609, 593 Tala et al., 2013
5 13.2 Di-HHDP- glucose 783 481, 301, 275 Gordon et al., 2011; Santos et al., 2011;
Tala et al., 2013
6 17.5 Di-HHDP-galloylglucose 935 633 Santos et al., 2011; Wu et al., 2012
7 21.0 Trigalloylglucose 635 465 Pfundstein et al., 2010; Gordon et al., 2011
8 26.7 Tetragalloylglucose 787 635, 617, 447 Gordon et al., 2011
9 27.7 Tetragalloylglucose 787 635, 617, 447 Gordon et al., 2011
10 28.4 Tetragalloylglucose 787 635, 617, 447 Gordon et al., 2011
11 29.2 Myricetin deoxyhexoside 463 317 Gordon et al., 2011
12 31.6 Pentagalloylglucose 939 769, 617 Gordon et al., 2011
13 35.9 Acylated myricetin deoxyhexoside 505 463, 316 Gordon et al., 2011
14 37 Acylated myricetin deoxyhexoside 505 463, 316 Gordon et al., 2011
15 42.3 Acylated methylmyricetin deoxyhexoside 519 477, 331, 315 Gordon et al., 2011
HHDP, hexahydroxydiphenoyl.
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FIGURE 3 | Effect of hydroethanolic extract of S. cumini leaf (HESc) on morphometric parameters. 60 days-old lean and obese rats were treated or not
with HESc (500 mg/kg/day, v.o.) for 30 days. (A) Body weight evolution and (B) area under curve (AUC) are shown for all groups. Initial (day 0) and final (day 30)
values for (C) Lee Index [body weight (g)1/3/naso-anal length (cm) × 100]; and (D) food intake are also shown. Results are expressed as mean ± SEM (n = 6–8 per
group). Letters indicate significant difference (p < 0.05) against aLean; bLean+HESc; cObese; or dObese+HESc, analyzed by one-way ANOVA followed by
Newman–Keuls post-test.
adipocyte differentiation, as well as, to promote insulin-like
effects (Bai et al., 2008). The (epi)gallocatechins are important
proanthocyanidins with inhibitory activity against α-amylase, a
particularly interesting property for diabetes treatment (Wang
et al., 2012). Compound 4, which was tentatively identified as
an epigallocatechin gallate derivative, has been shown to improve
insulin secretion and protect pancreatic β-cells from glucotoxicity
(Cai and Lin, 2009). To the best of our knowledge, this is the
first time that flavan-3-ols like epigallocatechin gallate has been
found in S. cumini leaf. Overall, the polyphenolic profile herein
described for HESc not only ensures our extract genuineness,
but also strengthens our pursuit for the mechanisms of action
underlying the important biological properties that are reported
in this work.
HESc Improves Morphometric
Parameters and Attenuates Weight Gain
in Obese Rats
We sought to investigate in vivo and ex vivo effects of oral
chronic administration of HESc on morphometric and metabolic
profiles of lean and MSG-obese rats. Since there are no published
pharmacokinetic studies available for S. cumini extracts, we
took into consideration parameters established for other plant
species (Lei et al., 2003; Li et al., 2008) to estimate a dose of
500 mg/kg/day to allow secondary metabolites present in HESc
to reach biologically relevant steady state plasma concentrations.
Notwithstanding, polyphenolic compounds, e.g., flavonols and
procyanidins, are kept stable during gastric transit, although
factors like gut microflora or specific tissue perfusion rate might
interfere on their bioavailability at biological targets (Fraga and
Oteiza, 2011).
Consistent with previous reports, prior to HESc treatment,
obese rats were lighter, despite having higher Lee Index and
similar daily food consumption, compared to lean controls
(Figure 3) (Olney, 1969; Millard et al., 1982). After 30-days of
treatment, HESc-treated obese rats were ∼60% lighter (173 ± 7
to 199 ± 9 g) than obese rats without treatment (181 ± 13 to
245± 15 g) (p < 0.05 Figure 3A). Calculation of area under body
weight curve showed HESc prevented weight gain in both lean
and obese rats (Figure 3B), whereas no difference was observed
in the final body weight between lean groups (Figure 3A). HESc
also decreased the Lee Index from 336 ± 5 to 328 ± 4 in
MSG+HESc rats (Figure 3C), despite no changes in food intake
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(Figure 3D). Lee Index is a surrogate formula to assess rodent
body mass, especially in MSG-obese rodents, which show stunted
growth (Bernardis and Patterson, 1968), but is not very useful
for dietary or developmental obese models (Stephens, 1980).
Additionally, HESc consistently decreased white adipose tissue
depots in obese+HESc rats, with no effect on lean controls
(Table 2). HESc had no effect on brown adipose tissue, skeletal
muscle or liver relative masses (Table 2).
To further characterize HESc effects on adiposity, we
measured basal and isoproterenol-evoked ex vivo lipolysis in
periepididymal fat pads from all groups. Basal unstimulated
lipolysis was increased 2-fold in obese+HESc rats, as compared
to MSG controls (Figure 4; 2.7 ± 0.4 vs. 4.8 ± 0.4 µg/mg/h,
p < 0.05); this level of lipolysis in the HESc-treated obese rats
approached the levels seen in lean rats (7.0 ± 1.1 µg/mg/h).
Upon sympathetic stimulus with 20 µM isoproterenol, lipolytic
activity showed very similar increases between HESc-treated and
not treated rats from the same group, suggesting HESc had no
further adrenergic impacts (Figure 4). Of note, obese rats, treated
or not, presented lower lipolytic activity (Figure 4) that could be
attributed to the low sympathetic activity already described for
MSG obesity model (Martins et al., 2004). It has been shown that
a flavonoid-rich extract from S. cumini seed (100 µg/mL, 8 days)
upregulated both PPAR-α and PPAR-γ in 3T3-L1 preadipocytes
(Sharma et al., 2008), which may improve adipocyte homeostasis
leading to lower fat accumulation in vivo. Furthermore, 100 µM
myricetin (Wang et al., 2015) and 10 µM epigallocatechin gallate
(Chan et al., 2011) have been shown to enhance lipolysis and
downregulate mRNA levels of adipogenesis-related transcription
factors in the same 3T3-L1 preadipocytes. Considering the
variety of myricetin derivatives found in HESc, besides other
polyphenols, it is plausible that the anti-obesity properties herein
described for S. cumini leaf may be due similar mechanisms,
although this remains to be confirmed.
HESc Improves Triglyceride Levels in
Serum, Liver, and Skeletal Muscle of
Obese Rats
Concomitant with the effects on white adipose tissue
accumulation, HESc also improved the serum biochemical
profile of obese animals. Overnight fasting serum glucose levels
were not changed by HESc administration in either lean or
obese rats (Figure 5A); although serum triglyceride levels were
strongly decreased in HESc-treated obese rats by 45% from
237 ± 36 mg/dL (obese) to 129 ± 13 mg/dL (obese+HESc); the
HESc-treated obese rats had serum triglycerides levels that were
not different from lean rats (lean 89 ± 7 mg/dL, lean+HESc
74 ± 6 mg/dL, Figure 5B). Total serum cholesterol levels were
also reduced by 20% in obese+HESc rats (70 ± 5 mg/dL), as
compared to obese rats (89 ± 6 mg/dL) (p < 0.05 Figure 5C).
Hepatic as well as skeletal muscle triglyceride accumulation
were ∼threefold higher in obese versus lean rats, but treatment
with HESc normalized these levels found in lean animals. There
were no significant differences in total cholesterol content
in liver or skeletal muscle between any treatment groups
(Table 2). Since triglyceride-rich VLDL particle overproduction
is tightly associated with hepatic IR (Kamagate et al., 2008), we
calculated TyG Index as a surrogate measure of hepatic insulin
sensitivity (Simental-Mendia et al., 2008). HESc partially restored
insulin sensitivity of obese rats, as TyG values were decreased
from 9.5 ± 0.1 (obese) to 8.7 ± 0.1 (obese+HESc, p < 0.05,
Figure 5D), although it was still different from lean control rats
(lean 8.4 ± 0.1, lean+HESc 8.2 ± 0.1, p < 0.05). TyG Index is
well validated for IR prediction in humans (Vasques et al., 2011;
Du et al., 2014), but has also been increasingly applied for animal
studies as well (Gonzalez-Torres et al., 2015; Motta et al., 2015).
Even though we have not measured gene or protein expression
of hepatic insulin signaling pathway markers, constituting a
TABLE 2 | Morphological parameters and lipid profiles of insulin-sensitive tissues upon HESc 30-days treatment of lean and MSG-obese rats.
Lean Lean+HESc MSG MSG+HESc
Morphological parameters (g/100g BW)
Retroperitoneal fat 0.70 ± 0.15 0.60 ± 0.11 3.59 ± 0.20a,b,d 2.60 ± 0.17a,b,c
Periepididymal fat 0.70 ± 0.14 0.64 ± 0.07 4.63 ± 0.28a,b,d 2.91 ± 0.21a,b,c
Mesenteric fat 0.62 ± 0.10 0.57 ± 0.09 2.73 ± 0.15a,b,d 2.24 ± 0.25a,b,c
Interscapular brown fat 0.07 ± 0.002 0.07 ± 0.003 0.17 ± 0.02a,b 0.16 ± 0.01a,b
Liver 3.3 ± 0.3 2.9 ± 0.1 2.5 ± 0.1a 2.5 ± 0.1a
Soleus muscle 0.04 ± 0.002 0.04 ± 0.002 0.03 ± 0.002a,b 0.03 ± 0.002
Gastrocnemius muscle 0.55 ± 0.03 0.59 ± 0.01 0.45 ± 0.04 0.45 ± 0.03
Liver lipid profile(mg/g)
Total fat 185 ± 19 197 ± 19 267 ± 19a,b,d 187 ± 17c
Triglycerides 5.9 ± 0.7 6.9 ± 0.3 18.4 ± 2.4a,b,d 8.7 ± 1.0c
Total cholesterol 2.6 ± 0.2 3.0 ± 0.3 2.8 ± 0.4 2.5 ± 0.2
Skeletal muscle lipid profile (mg/g)
Total fat 259 ± 13 283 ± 26 259 ± 11 268 ± 25
Triglycerides 4.4 ± 0.6 5.2 ± 1.0 13.2 ± 1.4a,b,d 8.0 ± 1.0c
Total cholesterol 1.4 ± 0.1 1.5 ± 0.2 1.3 ± 0.1 1.3 ± 0.1
Data represent mean ± SEM (n = 6–8), comparison between group pairs were performed by ANOVA, using Newman–Keuls as post-test. Superscript letters indicate
statistical difference (p < 0.05) against aLean, bLean+HESc, cMSG, dMSG+HESc. Tissues were collected upon euthanasia performed after 12-h fasting.
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FIGURE 4 | Effect of hydroethanolic extract of S. cumini leaf (HESc) on lipolytic activity of periepididymal white adipose tissue. Basal (−) and 20 µM
isoproterenol (ISO)-induced lipolytic activity was assessed in peridepididymal white adipose tissue samples collected from 90 days-old lean and obese rats treated or
not with HESc (500 mg/kg/day, v.o.) for 30 days. Results are expressed as mean ± SEM (n = 6–8 per group). Letters indicate intra-group significant difference
(p < 0.05) against abasal (−); b ISO (+); cHESc (−); or dHESc/ISO (+), analyzed by one-way ANOVA followed by Newman–Keuls post-test. ∗p < 0.05 Lean basal (−)
vs. Obese basal (−) inter-group analysis.
limitation in this work, our data strongly suggest that HESc
targeted triglyceride biosynthetic pathways through mechanisms
that might involve the improvement of insulin-dependent
actions.
In a recent work, we showed that hypertriglyceridemia
observed in MSG-obese rats is associated to activation of
ER-stress pathways and increased expression of microsomal
triglyceride-transfer protein (MTP) in the liver, resulting in
higher VLDL assembly (Franca et al., 2014). MTP gene
expression is controlled by transcription factor forkhead box
O1 (FoxO1) phosphorylation, which is reduced under insulin
resistant conditions (Kamagate et al., 2008). Regarding the anti-
dyslipidemic properties of S. cumini, it has been particularly
demonstrated that ethanolic extracts from seed (100 mg/Kg/day,
21 days) or seed kernel (100 mg/Kg/day, 30 days) inhibit
HMG-CoA reductase, the rate-limiting enzyme of cholesterol
biosynthesis (Ravi et al., 2005; Sharma et al., 2008). However,
our data showed that HESc completely reverted triglyceride
accumulation in bloodstream and insulin-sensitive tissues,
specifically liver, and skeletal muscle, of obese+HESc rats,
which led us to speculate that HESc might improve peripheral
insulin sensitivity. Indeed, the effects of HESc on hepatic and
serum lipid profiles resemble those described for green tea (–)-
epigallocatechin-3-gallate, which were attributed to a modulatory
effect on lipogenic overexpressed genes of mice fed a high-fat diet
(Lee et al., 2009). In high fat-fed rats, treatment with myricetin
(300 mg/Kg/day, 8 weeks) resulted in significant lowering of
plasma and hepatic triglycerides accumulation, an effect ascribed
to overexpression of PPARα-related enzymes, which decreases
the intracellular levels of fatty acids available for triglyceride
synthesis in response to decreased IR (Chang et al., 2012). Similar
effects have been described for S. cumini extracts (Sharma et al.,
2012) and further support hepatic IR amelioration as the leading
pathway by which S. cumini and its metabolites restore VLDL
assembly and serum triglyceride levels in this study.
HESc Restores Insulin-Glucose
Homeostasis in MSG-Obese Rats
In order to further investigate the effects of HESc on
insulin-glucose axis function, all animals were subjected to
intraperitoneal glucose (ipGTT) and insulin (ipITT) tolerance
tests at the end of treatment, with a 3-days gap between tests for
proper volemic recovery. Baseline tail vein blood samples were
taken for measurement of fasting and fed glucose levels, as well
as, fasting insulin levels. There were no differences in fasting
or fed serum glucose levels between any groups (Figures 6A,B,
respectively). Upon intraperitoneal glucose loading for ipGTT,
all groups reached maximal glucose levels within 15 min. HESc
brought glucose levels at peak (obese+HESc, 188 ± 12 mg/dL)
back to values near those of lean rats, while obese rats reached
mean values 220 ± 12 mg/dL at the peak, persisting at higher
levels throughout the test (Figure 6C, p < 0.05). Calculation of
ipGTT area under curve (AUC) showed that glucose tolerance
was partially restored in obese+HESc animals (Figure 6D),
achieving intermediate values between lean and obese rats.
Figure 6E shows that fasting insulin levels in obese rats
were ∼threefold higher than lean controls (lean, 0.55 ± 0.06;
lean+HESc, 0.68 ± 0.14; obese, 1.76 ± 0.25 ng/mL; p < 0.05),
whereas HESc decreased insulin levels in obese rats by 42%
(obese+HESc rats 0.98± 0.22 ng/mL; p < 0.05). Consistent with
these data, calculation of KITT showed that insulin sensitivity
was completely restored in obese+HESc rats, while obese rats
presented values as low as half the other groups (Figure 6F).
These results were further confirmed by assessment of HOMA-
IR Index, which showed that peripheral insulin sensitivity in
obese+HESc rats was completely restored and identical to lean
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FIGURE 5 | Effect of hydroethanolic extract of S. cumini leaf (HESc) on serum biochemical parameters. Serum levels of glucose (A), triglycerides (B), total
cholesterol (C) were measured in blood samples collected from overnight fasting 90 days-old Lean and Obese rats treated or not with HESc (500 mg/kg/day, v.o.)
for 30 days. (D) TyG Index was calculated from fasting glucose and triglyceride levels to infer insulin resistence. Results are expressed as mean ± SEM (n = 6–8 per
group). Letters indicate significant difference (p < 0.05) against aLean; bLean+HESc; cObese; or dObese+HESc, analyzed by one-way ANOVA followed by
Newman–Keuls post-test.
rats (Figure 6G). Moreover, calculation of HOMA-B Index
further suggested that HESc might interfere in the well-described
insulin oversecretion of MSG-obese rats (Figure 6H).
The MSG model is an animal model of prediabetic
metabolic syndrome, in which animals do not necessarily exhibit
dysglycemia or hyperglycemia, despite being hyperinsulinemic,
insulin-resistant, dyslipidemic, and abdominally obese (Olney,
1969). In fact, it has been observed MSG-obese rats as old as
6-months to present lower glycemia when compared to lean
controls (Liu et al., 2011). Thus, facing the normoglycemic
status of our rats, the absence of a hypoglycemiant effect on
HESc-treated rats should not be considered a limitation in this
study, rather it is in accordance with previous observations
that glucose lowering properties of S. cumini constituents are
more effective under hyper- than normoglycemic conditions
(Ayyanar et al., 2013). Antidiabetic properties of S. cumini have
been extensively studied since the mid-19th century, but no
precise mechanistic action for any of its secondary metabolites
has been proposed (Helmstadter, 2008; Ayyanar et al., 2013).
Our data suggest that HESc was able to improve glucose
tolerance as a result of increases in insulin sensitivity. These
results are consistent with a previous report in which aqueous
extract of S. cumini seeds (400 mg/Kg/day, 21 days) was found
to improve insulin sensitivity through modulation of hepatic
PPARγ downstream pathways (Sharma et al., 2012), an effect
also described for a flavonoid-rich extract from S. cumini seeds
on 3T3-L1 preadipocytes (Sharma et al., 2008). Considering leaf
properties, methanolic extract of leaves (100 ng/mL) was found
to increase mRNA expression of GLUT-4 glucose transporter
and phosphatidylinositol-3 kinase (PI3 kinase) in L6 myotubes,
both important mediators of insulin action in adipocytes and
skeletal muscle (Anandharajan et al., 2006). Of note, very similar
effects have been described for myricetin (Liu et al., 2007; Chang
et al., 2012), which is highly prevalent in our HESc extract
(Table 2). Finally, fasting serum insulin levels of obese+HESc
rats were decreased to nearly 50% of those found in obese rats,
leading us to hypothesize that abovementioned improvement of
peripheral metabolic status might also exert a role on insulin
secretion. Free fatty acids directly stimulate insulin release
through activation of G protein-coupled receptor 40 (GPR40) on
pancreatic β-cell surface (Itoh et al., 2003). Although we did not
measure circulating levels of free fatty acids, a limitation in this
report, obese+HESc rats showed strong decrease of triglyceride
levels (Figure 5B; Table 2), which may lead to lower GPR40
Frontiers in Pharmacology | www.frontiersin.org 8 March 2016 | Volume 7 | Article 48
fphar-07-00048 March 8, 2016 Time: 17:57 # 9
Sanches et al. Syzygium cumini Dual Effect in MSG-Obese Rats
FIGURE 6 | Effect of hydroethanolic extract of S. cumini leaf (HESc) on insulin-glucose axis function. Intraperitoneal glucose (ipGTT) and insulin (ipITT)
tolerance tests were performed to examine insulin-glucose axis function in 90 days-old Lean and Obese rats treated or not with HESc (500 mg/kg/day, v.o.) for
30 days. (A) Fasting and (B) fed serum glucose levels were measured in blood drops collected by tail-cut method. (C) Changes in tail blood glucose during ipGTT
and (D) total blood glucose accumulation reported as AUC. (E) Fasting plasma insulin levels. Insulin sensitivity was assessed by (F) K ITT, which measure glucose
disappearence rate from bloodstream and (G) HOMA-IR, homeostasis model index for insulin resistance (IR). (H) HOMA-B, homeostasis model index for β-cell
function. Results are expressed as mean ± SEM (n = 6–8 per group). Letters indicate significant difference (p < 0.05) against aLean; bLean+HESc; cObese; or
dObese+HESc, analyzed by one-way ANOVA followed by Newman–Keuls post-test.
activation and consequent decrease of insulin secretion. Our data
are further supported by recent findings that methanol extract
of Baccharis dracunculifolia (400 mg/Kg/day, 30 days) decreased
serum insulin levels in MSG-obese rats subsequent to improved
peripheral insulin sensitivity (Hocayen et al., 2015), in spite of
insulin oversecretion caused by high parasympathetic activity on
pancreatic islets of MSG-obese rodents (Miranda et al., 2014).
Authors attributed this effect to the high antioxidant capacity of
the extract (Hocayen et al., 2015), a property well-demonstrated
by HESc.
Ex Vivo Insulin Release is Increased in
Isolated Pancreatic Islets from
HESc-Treated Lean and Obese Rats
We next assessed the effect of 30-days HESc treatment on
glucose-stimulated insulin secretion in pancreatic islets isolated
from lean and obese rats. Sets of 4 islets, in a minimum of
four sets per animal, were incubated under basal (5.6 mM
glucose) or stimulating (16.7 mM glucose) conditions for
1 h at 37◦C. Basal insulin release was almost 80% higher
in lean+HESc (0.43 ± 0.05 ng/mL/h; Figure 7A) than lean
rats (0.24 ± 0.02 ng/mL/h, p < 0.05); but no significant
increase was observed in obese+HESc rats over their obese
counterparts. With increased glucose, insulin secretion in
lean+HESc (1.84± 0.24 ng/mL/h) kept a similar elevation of 90%
over lean controls (0.96 ± 0.14 ng/mL/h; Figure 7A, p < 0.05).
Meanwhile, insulin release from islets isolated from obese+HESc
rats (3.20 ± 0.39 ng/mL/h) was only 37% higher than that of
obese animals (2.32 ± 0.22 ng/mL/h; Figure 7A, p < 0.05). The
lower proportional increase of glucose-stimulated insulin release
in obese+HESc rats allows us to suggest that pancreatic islets of
MSG-obese rats are exhausted or have a potential impairment
on the biochemical pathway by which HESc is promoting its
secretagogue effect. Notably, pancreatic islets from all groups
showed similar four to fivefold increase in insulin release with
glucose stimulation, suggesting there must be some preserved
secretory responsiveness to glucose (Figure 7A).
Glucose is the major physiological stimulator of insulin
stimulus-secretion coupling, since it promotes an increase of
ATP/ADP ratio with consequent closure of ATP-sensitive K+
channels (K+ATP), β-cell membrane depolarization and Ca2+
influx that triggers insulin-containing granules exocytosis (Sweet
et al., 2004). However, glucose also elicits insulin secretion by way
of K+ATP channel-independent pathways (Gembal et al., 1993).
It has been shown that adult MSG-obese rats have preserved
functioning of the K+ATP channel-dependent pathway despite
showing dysfunctional K+ATP channel-independent pathways.
It has been speculated that glycolitic metabolism is enhanced
in β-cells from MSG-obese rats, resulting in a lower threshold
for glucose-stimulated insulin secretion (Grassiolli et al., 2006).
Indeed, our data are consistent with this, since isolated islets
from obese and obese+HESc rats showed increased insulin
secretion at both 5.6 and 16.7 mM glucose, compared to
lean controls. Concerning insulinotropic effects of S. cumini
extracts, early reports demonstrated in vivo and in vitro
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FIGURE 7 | Effect of hydroethanolic extract of S. cumini leaf (HESc) on ex vivo and in vitro glucose-stimulated insulin secretion (GSIS). (A) GSIS (5.6
and 16.7 mM glucose) in pancreatic islets isolated from 90 days-old Lean and Obese rats treated or not with HESc (500 mg/kg/day, v.o.) for 30 days. (B) GSIS (5.6
and 16.7 mM glucose) in pancreatic islets isolated from control not-treated rats and incubated with increasing concentrations of HESc (10–1000 µg/mL). In both
(A,B), at least four groups of four islets per animal were incubated for 1 h at 37◦C under denoted conditions. (C) GSIS (3.3 and 16.7 mM glucose) in INS-1E β-cells
(2 × 105 cells/well) incubated with 100 and 1000 µg/mL HESc for 4 h at 37◦C. Results are expressed as mean ± SEM (n = 6–8 per group). In (A), letters indicate
significant difference (p < 0.05) against aLean; bLean+HESc; cObese; or dObese+HESc. In (B), letters indicate significant difference (p < 0.05) against basal (a, w/o
HESc) or 10–1000 µg/mL HESc (b–f, respectively). In (C), letters indicate significant difference (p < 0.05) against basal (a, w/o HESc) or 100 and 1000 µg/mL HESc
(B,C, respectively). All data were analyzed by one-way ANOVA followed by Newman–Keuls post-test.
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insulin releasing properties exerted by fruit-pulp and seed
extracts, emphasizing they were more pronounced on pancreatic
islets from normoglycemic than hyperglycemic streptozotocin-
induced diabetic rats (Achrekar et al., 1991). More recently,
it was shown that a partially purified fraction from fruit-pulp
(25 mg/Kg/day, 7 or 15 days) totally restored glucose-stimulated
insulin release in alloxan-induced diabetic rabbits by way of a
hypothesized sulphonylurea-like mechanism of action (Sharma
et al., 2006). Our data do not support this hypothesis, since
islet insulin release from HESc-treated did not change their
sensitivity to glucose compared to untreated rats, diminishing
the possibility of an additional effect on K+ATP channel-
dependent mechanisms. On the other hand, the insulinagogue
effect of dietary flavonoids is well documented (Fraga and
Oteiza, 2011) and might support the effects herein presented for
HESc. For instance, catechin-derivatives like (epi)gallocatechin-
(epi)gallocatechin-O-gallate, which is present in our HESc extract
(Table 1), were shown to promote insulin secretion by improving
β-cell mitochondrial function, in addition to other effects
like antioxidant, antiinflammatory, and glucotoxicity prevention
(Cai and Lin, 2009). Nevertheless, HESc-treated obese rats
had reduced serum insulin levels (Figure 6E), in spite of a
higher ex vivo insulin release response under hyperglycemic
conditions (Figure 7A), very similar to the effects of Baccharis
dracunculifolia methanol extract on MSG-obese rats (Hocayen
et al., 2015). This particular set of data is suggestive of a role
for HESc as an activator of peripheral pathways evoked either
by recovery of peripheral insulin sensitivity (Figure 6F), or
by lowering of serum lipids (Figure 5), which may promote
decreased in vivo insulin release in our obese+HESc rats.
HESc Directly Promotes In Vitro Insulin
Release in Pancreatic Islets and a β-Cell
Line
To further assess the insulinogogue capacity of HESc, we
incubated pancreatic islets isolated from lean normoglycemic rats
with increasing concentrations of HESc, from 10 to 1000 µg/mL.
Isolated islets showed a fourfold increase in glucose-estimulated
insulin secretion when glucose concentration was increased from
5.6 to 16.7 mM (Figure 7B). Thereafter, HESc was added for
1 h to the incubation medium under both glucose conditions.
Increasing concentrations of HESc improved insulin secretion
in a bell-shaped manner with maximal response at 100 and
300 µg/mL (Figure 7B). No effect was seen under either
the lowest or the highest concentrations of HESc, suggesting
that HESc constituents probably act more as modulators than
stimulators of insulin secretion. Similarly our data on ex vivo
insulin secretion (Figure 7A), direct incubation of isolated islets
with HESc did not potentialize the glucose-evoked fourfold
increase of insulin secretion under 16.7 mM glucose, further
suggesting a modulatory role for the secondary metabolites
indentified in HESc.
Although insulin-secreting β-cells are the main cellular
component of islets, it has been shown that non-β-cells, i.e.,
α- δ- and pancreatic polypeptide cells, are crucial components
of insulin secretion homeostasis (Brereton et al., 2015). Thus,
to examine whether HESc targets β-cell machinery, HESc was
also incubated with rat insulinoma-derived INS-1E cells, which
is a well-characterized model for studies on β-cell function
(Merglen et al., 2004). Incubation of 100 µg/mL HESc in
INS-1E cells doubled the insulin secretion for both glucose
concentrations (Figure 7C), in spite of the fact that the cells
failed to show increased insulin release under 16.7 mM glucose,
which constitutes a limiting aspect in our study but already
observed by others (Merglen et al., 2004). It has been shown
that quercetin, a flavonoid already described in S. cumini leaf
(Ruan et al., 2008) but not identified in our HESc phytochemical
characterization, promotes insulin secretion by direct activation
of L-type calcium channel in INS-1E cells (Bardy et al., 2013).
A similar L-type calcium channel-activating effect was described
for myricetin (Fusi et al., 2003), whose derivatives were identified
in our HESc extract. Thus, we speculate that any or even some
of the compounds contained in HESc may act in a similar way,
either isolatedly or collectively within a phytocomplex.
The unexpected decrease of insulin secretion caused by
1000 µg/mL HESc in our cells, led us to assess its possible
cytotoxicity over INS-1E cells. Trypan blue and BrdU assays
were used and showed that HESc resulted in significant cell
death only at this concentration (data not shown). This is
consistent with a previously reported antiproliferative effect of
hydroethanolic extracts (12.5–200 µg/mL, 72 h) from fruit pulp
or seed of S. cumini on lung cancer cells (Aqil et al., 2012),
although myricetin has been described to protect RIN-m5f β-cells
from cytokine-induced cell death (Ding et al., 2012). Since islet
basal insulin secretion was maintained under this same HESc
concentration in islet cultures (Figure 7B), we speculate that
islet architecture may help to protect β-cells from the HESc
cytotoxicity seen in INS-1E cells. This is consistent with the
observation that a purified fraction isolated from S. cumini seeds
(8 mg/Kg/day, 21 days) induced regenerative islets neoformation
in streptozotocin-induced diabetic mice (Dusane and Joshi,
2011). Despite the abovementioned cytotoxic effect in INS-
1E cells, hydroethanolic extract of S. cumini leaf, at dosis as
high as 2 g/Kg, has been shown to be free of toxicity when
chronically administered by oral route to rodents (Silva et al.,
2012). Futhermore, one must recognize the possible metabolism
of HESc compounds as a result of the first-pass through the liver
potentially creating other unknown metabolites and need to be
addressed in future pharmacokinetic studies.
CONCLUSION
Although we have prioritized functional instead of molecular
approaches in this study, considering the polyphenolic profile
and the antioxidant capacity it confers to HESc, we speculate
that the mechanisms whereby HESc acts appears to involve
two pathways. The first is an improving effect on peripherally
disrupted insulin action, supported by our observations of weight
gain slowdown and effective IR overcome, as assessed in KITT ,
higher lipolytic activity, reversal of triglycerides accumulation
and improved glucose tolerance. The second pathway, likely to be
synergistic with the first; may be a direct stimulatory/modulatory
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effect on pancreatic islet function, which disregards local glucose
levels but probably involve the restoration of β-cell cytosolic
redox status. To the best of our knowledge, it is the first
time an insulinagogue effect is reported for S. cumini leaf.
In conclusion, data presented in this study demonstrate the
pharmacological relevance of S. cumini leaves as a potential
source of bioactive compounds for the treatment of MetS
and its associated comorbidities, especially presenting glucose
intolerance, IR and/or pancreatic islet failure.
MATERIALS AND METHODS
Plant Material and Preparation of
Hydroethanolic Extract
Fresh leaves of Syzygium cumini (L.) Skeels were collected from
different trees at Bacanga’s Campus of the Federal University of
Maranhão (2◦33′11.7′′S 44◦18′22.7′′W), in São Luís, Maranhão,
Brazil. Plant species authentication was performed by Prof. Dr.
Eduardo Bezerra Almeida Jr., botanist of MAR – Herbarium of
Maranhão – where a voucher specimen is deposited under #4574.
Leaves were dried at 38◦C in air-flow oven before pulverization
and maceration in 70% ethanol (1: 6, w/v) for 3 days (solvent
was replaced every 24 h) under continuous stirring at room
temperature. Collected extract was evaporated under reduced
pressure and lyophilized to yield the hydroethanolic extract of
S. cumini leaf (HESc). HESc aliquots were kept at 4◦C, protected
from light, until further experimental use, when powdered HESc
was resuspended in distilled water at desired concentrations.
Assessment of Total Polyphenolic
Content and Antioxidant Capacity
Prussian Blue method was applied for determination of
total polyphenolic content in HESc, as previously described
(Pueyo and Calvo, 2009). GA was used as standard and
results expressed as GA equivalents per 100 g dry extract
(GAE/100 g). Antioxidant capacity of HESc was assessed
through 2,2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid
(ABTS•+) and 1,1-diphenyl-2-picrylhydrazyl (DPPH•) assays,
as previously described (Floegel et al., 2011), using quercetin
and GA as standards, respectively. All assays were performed
in quadruplicate using freshly made solutions of HESc and
standards.
HPLC-MS/MS Analysis
Analysis were performed by HPLC-MS/MS using a
chromatograph LC-20A Prominence (Shimadzu, Japan)
equipped with autoinjector and detector SPD-20A/UV-Vis.
HPLC separation was conducted on Luna C-18 analytical
column (250 mm × 4.6 mm, 5 µm, Phenomenex), at a flow
rate of 1 mL/min. Gradient elution was performed by using
0.1% formic acid acidified H2O (A) and acetonitrile (B), as
mobile phases. Elution was performed according to the following
conditions: 0–1 min 5% B; 1–30 min, 5–30% B; 30–60 min,
30–70% B, at 40◦C and fingerprints detected at 254 nm. All
solvents were purchased from Merck Millipore Co. (Germany)
and degassed using ultrasonic bath. For analysis, HESc samples
were dissolved in 70% EtOH (100 µg/mL) and filtered through
0.45 µm mesh (Millipore) for an injection volume of 25 µL.
For mass spectra acquirement, chromatograph was coupled
to an Esquire 3000 Plus mass spectrometer (Bruker Daltonics,
Germany) with quadrupole ion trap analyzer in tandem mode
with electrospray ionization (ESI). Ionization settings: ESI source
voltage 40 V, potential 4 kV, temperature 320◦C, ultrapure helium
(He) as collision gas and nitrogen (N2) as nebulizer gas. The
desolvation was facilitated using a current flow of 7.0 L/min. Data
were acquired in full scan mode MS2 with negative ionization in
the range of m/z 100–3000. Data on retention time, mass charge
ratio (m/z) molecular ion and fragments were compared with
available data in the literature to tentatively identification of
phenolic compounds.
Neonatal Induction of Obesity and
Treatment with HESc
Newborn male Wistar rats (Rattus norvegicus, eight pups per
dam) were subcutaneously injected with MSG (4 g/kg; obese
group, Sigma–Aldrich) or equimolar saline solution (0.1 mL/10g,
lean group) during the first 5 days of life from postnatal day 2–
6) (Olney, 1969). After weaning (at postnatal day 21), animals
were weighed twice a week to assess weight gain and kept under
controlled conditions [RT 23 ± 2◦C, 12 h light/dark cycle,
filtered water and standard rodent chow (Nuvilab CR-1, Brazil)
ad libitum]. At age 60 days of age, obesity was assessed by the
calculation of the Lee Index, which is the quotient of the cube
root of body weight (g) per naso-anal length (cm) (Bernardis
and Patterson, 1968). All MSG-treated rats presented a Lee Index
value significantly higher than lean controls mean. Thereafter,
animals from MSG-treated and lean groups were randomly
allocated into four groups for treatment with HESc or saline for
30 consecutive days, as follow:
Lean, lean rats receiving 0.1 mL/kg/day saline by gavage
(n= 6).
Lean+HESc, lean rats receiving 500 mg/kg/day by gavage
(n= 7).
Obese, MSG rats receiving 0.1 mL/kg/day saline by gavage
(n= 8).
Obese+HESc, MSG rats receiving 500 mg/kg/day by gavage
(n= 8).
During the whole treatment period, HESc solutions were
freshly prepared by dissolving the lyophilized extract in saline.
Animals and not-eaten chow were weighed every 2 days for body
weight and food intake record. On treatment days 27 and 30,
animals were submitted to glucose and insulin tolerance tests,
respectively, as described later. After 30 days of treatment, Lee
Index was once more performed to assess the effect of treatment
on obesity. After overnight fasting, on day 31, the animals
were anesthetized (10 mg/kg xylazine, 40 mg/kg ketamine)
and subjected to retro-orbital bleeding for blood sample
collection and were killed by exsanguination. Pancreas, liver,
gastrocnemius, and soleus muscles, as well as periepididymal,
retroperitoneal, visceral fat pads and interscapular brown adipose
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tissue were collected and weighed for morphometric assessment
and further analyses. Morphometric data were expressed as tissue
mass (g) per 100 g body weight (%BW, g). All protocols were
approved by the Committee for Ethics and Welfare on Animal
Use – CEUA of the Federal University of Maranhão under ruling
N◦ 016/13.
Serum Biochemistry Assessment
Blood samples were collected into EDTA and non-EDTA tubes
to allow separation of both plasma and serum from all groups.
Serum was used for spectrophotometric measurement of glucose,
triglycerides and total cholesterol levels using commercial kits
according to manufacturer’s instructions (Labtest, Brazil). Plasma
was used for insulin measurement by radioimmunoassay (RIA)
using human insulin radiolabelled with 125I as tracer, rat insulin
as standard (Crystal Chem Inc.,USA) and rat insulin antibody
(donated by Dr Leclerq-Meyer, Free University of Brussels,
Belgium), according to previously described protocol (Scott et al.,
1981).
Liver and Skeletal Muscle Fat Extraction
and Measurement
Samples of gastrocnemius and liver (∼500 mg each) were
homogenized in 5 mL chloroform/methanol (2:1) solution, and
kept overnight at 4◦C. The resultant supernatant was filtered,
added to 0.9% NaCl (saline 1:5 filtrate), stirred and left to
stand for 2 h. Methanol and chloroform phases were separated
by centrifugation (1000 rpm, 5 min) and a 1 mL aliquot of
chloroform phase was collected and dried at 40◦C in air-flow
oven. Dry-fat was weighed and resuspended in 1 mL Triton-
X100/methanol (2:1) for spectrophotometric measurement of
triglycerides and total cholesterol levels using commercial kits
according to manufacturer’s instructions (Labtest, Brazil). Results
were expressed as total fat (mg) per tissue mass (g), triglycerides
(mg) per tissue mass (g), and total cholesterol (mg) per tissue
mass (g) (Freedman et al., 2005).
Ex Vivo Lipolytic Activity Assessment
Samples of periepididymal white adipose tissue (∼100 mg) was
shredded into small fragments and incubated in Krebs buffer
(120 mM NaCl; 15 mM NaHCO3; 4.83 mM KCl; 1.2 mM
MgSO4; 1.21 mM KH2PO4; 2.4 mM CaCl2, 1% BSA, and
0.1% glucose after pH adjustment to 7.4) under pumping
aeration for 1 h at 37◦C. For lipolytic activity assessment,
incubation of samples was undergone in absence (basal)
or presence of 20 µM isoproterenol (Sigma–Aldrich, USA).
Reactions were stopped on ice bath and glycerol concentration
on supernatant assessed by spectrophotometric measurement
using an triglyceride commercial kit according to manufacturer’s
instructions (Labtest, Brazil) (Vaughan, 1962).
Intraperitoneal Glucose and Insulin
Tolerance Tests
For intraperitoneal glucose tolerance test (ipGTT), animals were
submitted to 8-h fasting prior to administration of 2 g/kg
glucose (i.p.). Capillary blood drops were collected by tail-
cut method immediately before (time 0) and 15, 30, 60, and
120 min after injection for blood glucose measurement through
glucometer (Accu-check Active, Roche Diagnostic, Germany).
Similar procedure was carried out for intraperitoneal insulin
tolerance test (ipITT), excepting animals were fed and received
1 IU/kg insulin (Humulin R, Lilly, USA). Glucose disappearance
rate (KITT) was derived from ipITT data and calculated as
0.693/t1/2, where t1/2 is the half time to reach maximum blood
glucose decay.
Insulin Resistance Assessment
Insulin resistance was inferred from the calculation of TyG
Index (TyG= Ln[fasting triglycerides (mg/dL)× fasting glucose
(mg/dL)/2]) (Simental-Mendia et al., 2008), homeostasis model
assessment (HOMA) Index of IR (HOMA-IR = fasting insulin
(µU/mL)/fasting glucose (mM)/22.5) and HOMA Index of β-cell
function [HOMA-B = 20 × fasting insulin (µU/ml)/fasting
glucose (mM) – 3.5] (Matthews et al., 1985).
Pancreatic Islet Isolation and Static
Insulin Secretion Assays
Pancreatic islets from all groups were isolated by collagenase type
V (0.8 mg/mL, Sigma–Aldrich, USA) digestion, as previously
described (Bordin et al., 1995). For static insulin secretion assays,
at least four groups of four islets per animal were pre-incubated
in 24-wells plates for 45 min at 37◦C in 1 mL Krebs-Hepes buffer
(115 mM NaCl, 5 mM KCl, 2.6 mM CaCl2, 1 mM MgCl2, 10 mM
NaHCO3, 15 mM HEPES, supplemented with 5.6 mM glucose,
3 g/L BSA) under controlled environment (95% O2 + 5% CO2).
Afterward, incubation medium was replaced with fresh buffer
containing eather 5.6 or 16.7 mM glucose and incubated for one
additional hour. In another set of experiments, pancreatic islets
from 90-days-old lean not-treated rats were incubated in eather
5.6 or 16.7 mM glucose Krebs-Hepes buffer containing HESc in
the concentrations of 10, 30, 100, 300, and 1000 µg/mL for 1 h
under same conditions. At the end, plates were cooled on ice bath
and supernatants collected and appropriately stored at −20◦C
for posterior measurement of insulin concentrations by RIA, as
earlier described.
INS-1E β-Cell Line Culture and Insulin
Secretion
INS-1E β-cells, generously donated by Dr. Claes Wollheim
(University of Geneva, Geneva, Switzerland), were cultured in a
humidified atmosphere (95%), containing 5% CO2 in complete
medium RPMI 1640 (Sigma–Aldrich, Canada) supplemented
with 5% inactivated fetal calf serum (Hyclone, Logan, UT), 1 mM
sodium pyruvate, 50 mM 2-mercaptoethanol, 1 mM L-glutamine,
10 mM HEPES, 1 U/mL of penicillin and 1 mg/mL streptomycin
(Sigma–Aldrich). To examine the effects of HESc (freshly diluted
in water and filtered through 0.22 µm mesh) on insulin secretion,
INS-1E cells were seeded in 96 wells plate (2× 105 cells/well) 24-
h before the addition of HESc (100 or 1000 µg/mL) to culture
medium for 4 h. Subsequently, culture medium was washed
out with PBS (2×) and replaced by Krebs-Ringer Bicarbonate
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HEPES buffer (KRBH = 135 mM NaCl, 3.6 mM KCl, 5 mM
NaHCO3, 0.5 mM NaH2PO4, 0.5 mM MgCl2, 1.5 mM CaCl2, and
10 mM HEPES, 0.1% BSA, pH 7.4) without glucose for 1-h. Then,
KRBH was added 2.8 mM glucose for 30 min previous to the
incubation with KRBH containing either 3.3 or 16.7 mM glucose
for 2 h under the same atmosphere. Afterwhich, supernatants
were collected and stored at−20◦C for later insulin measurement
with ultra-sensitive rat insulin ELISA kit (Crystal Chem Inc,
USA) according to manufacturer’s instructions.
Statistical Analysis
Results are expressed as mean ± SEM (n = 6–8 per group).
Shapiro–Wilk test was applied for normality assuring. Intra- and
inter-group comparisons were carried out by one-way ANOVA
and multiple comparisons were obtained by Newman–Keuls
post-test for a significance level of 5% (p < 0.05).
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